Go to main navigation Go to main content Go to footnote

Publications

As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration.

Biarnés M, Monés J, Villalbí JR, Arias L. Eur J Ophthalmol. 2011 May-Jun;21 (3): 282-9.

Research is the only solution for the future to fight against blindness

It is only with your help that we can fight against blindness

Collaborate